Substituted Imidazopyrazine Compounds As Ligand Directed Degraders Of Irak3 - EP4562012
EP4562012
- Filing Date
- Jul 24, 2023
- Status
- Pending
- Grant Date
- Jun 4, 2025
- External Links
- Slate, Register, Google Patents
Bibliography
The patent EP4562012A1 was granted to Celgene on Jun 4, 2025 following the initial filing on Jul 24, 2023 under the application number The current legal status of the patent is Pending.
Patent Summary
Patent Family New
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Get instant alerts for new documents